Literature DB >> 16168795

Diabetes complications and depression as predictors of health service costs.

Gregory E Simon1, Wayne J Katon, Elizabeth H B Lin, Evette Ludman, Michael VonKorff, Paul Ciechanowski, Bessie A Young.   

Abstract

OBJECTIVE: The aim of this study was to assess the relative contributions of diabetes complications, depression and comorbid medical disorders to health service costs in adults with diabetes.
METHODS: A total of 4398 adult health plan members with diabetes completed a mailed survey. Depression was assessed using the nine-item PHQ. Health service costs, diabetes complications, glycohemoglobin levels and comorbid medical conditions were assessed using computerized health plan records.
RESULTS: Total health service costs were approximately 70% higher for individuals with major depression than for those without any depressive disorder (5361 US dollars over 6 months vs. 3120 US dollars, P<.001); this difference was consistent across all categories of health service costs. Diabetes complications were the strongest predictor of total costs (6845 US dollars for those with three or more complications vs. 1719 US dollars for those with none), but depression remained strongly associated with increased costs at all levels of diabetes severity.
CONCLUSIONS: Among people with diabetes, depression is associated with 50-75% increases in health service costs. This proportional difference is similar to that in general population samples, but the absolute dollar difference is much greater. The effect of depression on health service use is undoubtedly complex and not limited to unexplained physical symptoms among the worried well.

Entities:  

Mesh:

Year:  2005        PMID: 16168795     DOI: 10.1016/j.genhosppsych.2005.04.008

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  77 in total

1.  Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study.

Authors:  Wayne Katon; Courtney R Lyles; Melissa M Parker; Andrew J Karter; Elbert S Huang; Rachel A Whitmer
Journal:  Arch Gen Psychiatry       Date:  2011-12-05

2.  Theory in practice: helping providers address depression in diabetes care.

Authors:  Chandra Y Osborn; Cindy Kozak; Julie Wagner
Journal:  J Contin Educ Health Prof       Date:  2010       Impact factor: 1.355

3.  The difficulty of making psychology research and clinical practice relevant to medicine: experiences and observations.

Authors:  Rodger Kessler
Journal:  J Clin Psychol Med Settings       Date:  2008-02-16

4.  Integrating depression and chronic disease care among patients with diabetes and/or coronary heart disease: the design of the TEAMcare study.

Authors:  Wayne Katon; Elizabeth H B Lin; Michael Von Korff; Paul Ciechanowski; Evette Ludman; Bessie Young; Carolyn Rutter; Malia Oliver; Mary McGregor
Journal:  Contemp Clin Trials       Date:  2010-03-27       Impact factor: 2.226

5.  Depression and risk of hospitalizations for ambulatory care-sensitive conditions in patients with diabetes.

Authors:  Dimitry S Davydow; Wayne J Katon; Elizabeth H B Lin; Paul Ciechanowski; Evette Ludman; Malia Oliver; Michael Von Korff
Journal:  J Gen Intern Med       Date:  2013-01-17       Impact factor: 5.128

6.  Medical expenditures associated with major depressive disorder among privately insured working-age adults with diagnosed diabetes in the United States, 2008.

Authors:  Sundar S Shrestha; Ping Zhang; Rui Li; Theodore J Thompson; Daniel P Chapman; Lawrence Barker
Journal:  Diabetes Res Clin Pract       Date:  2013-03-13       Impact factor: 5.602

7.  Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification?

Authors:  Wayne Katon; Joan Russo; Elizabeth H B Lin; Susan R Heckbert; Andy J Karter; Lisa H Williams; Paul Ciechanowski; Evette Ludman; Michael Von Korff
Journal:  Psychosom Med       Date:  2009-10-15       Impact factor: 4.312

8.  Cognitive behavioural therapy in elderly type 2 diabetes patients with minor depression or mild major depression: study protocol of a randomized controlled trial (MIND-DIA).

Authors:  Frank Petrak; Martin Hautzinger; Kristin Plack; Kai Kronfeld; Christian Ruckes; Stephan Herpertz; Matthias J Müller
Journal:  BMC Geriatr       Date:  2010-05-04       Impact factor: 3.921

9.  Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial.

Authors:  Diana Echeverry; Petra Duran; Curley Bonds; Martin Lee; Mayer B Davidson
Journal:  Diabetes Care       Date:  2009-09-03       Impact factor: 17.152

10.  Cost-effectiveness analysis of cognitive behaviour therapy for treatment of minor or mild-major depression in elderly patients with type 2 diabetes: study protocol for the economic evaluation alongside the MIND-DIA randomized controlled trial (MIND-DIA CEA).

Authors:  Nadja Chernyak; Frank Petrak; Kristin Plack; Martin Hautzinger; Matthias J Müller; Guido Giani; Andrea Icks
Journal:  BMC Geriatr       Date:  2009-07-01       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.